Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Cancer Biol Ther
GSK269962A at concentration of 50nM could dramatically inhibit basal myometrial contraction at 72h and abolish the procontractile effect of LPS
CC-115 is evaluated using both once (qd) and twice (bid) daily dosing schedules
is a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth
LEE011 succinate hydrate(1:1:x) Catalog No.:M9046-2 Cancer Biol TherLEE011 succinate hydrate is an orally available cyclin dependent kinase (CDK) inhibitor targeting cyclin D1 CDK4 and cyclin D3 CDK6 cell cycle pathway, with potential antineoplastic activity. CDK4 6 inhibitor LEE011 specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation prevents CDK mediated G1 S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing
US$ 133.00
US$ 157.50
US$ 195.00
US$ 195.00
US$ 107.50
US$ 190.00
US$ 150.00
US$ 112.50
US$ 4987.50
US$ 115.50